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Familial chilblain lupus is a monogenic form of cuta-
neous lupus erythematosus characterized by cold-
induced cutaneous lesions at acral location. It is caused
by loss-of-function mutations in the nucleic acid metabo-
lizing enzymes TREX1 or SAMHD1. Gain-of-function
mutations in STING (stimulator of Interferon genes)
have been described in an infancy-onset autoinflamma-
tory syndrome with fever, inflammatory cutaneous
lesions and interstitial lung disease.
Here we report on a family with dominant chilblain
lupus over 4 generations. Affected family members pre-
sented with acral inflammatory and partially necrotizing
lesions beginning in early childhood. In some cases,
low-titered ANAs and immune complexes were detect-
able. The family tested negative for TREX1 or SAMHD1
mutations. Exome sequencing revealed a heterozygous
STING mutation segregating with chilblain lupus in the
family. The mutation affects a highly conserved residue
within the STING dimer interface and is predicted to be
pathogenic. Quantitative RT-PCR analysis showed an
increased expression of IFN-stimulated genes in blood
cells of affected family members suggesting that the
identified mutation has an activating effect on type I
IFN signaling. Taken together, our findings demonstrate
that gain-of-function mutations in STING can cause
familial chilblain lupus and expand the spectrum of type
I interferonopathies.
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